Is online Adaptive Radiotherapy justified in terms of patient outcomes? : Do we have sufficient long-term studies?
For which treatment sites the cost-benefit analysis is proved to be positive? Challenges such as dose calculation inaccuracies in lung mediums, demanding resources, not a great CBCT imaging system for soft tissue can challenge its implementation and caution centres.
Online Adaptive Radiotherapy can improve patient outcomes by personalizing treatment based on real-time changes in tumor size and position. It is often justified for sites where tumors are prone to significant variability, such as in the prostate, bladder, and head and neck regions. The cost-benefit analysis tends to be positive for these sites due to the potential for improved precision and reduced side effects, which can outweigh the higher costs of adaptive radiotherapy.
- Badges
- Science topic
- Similar topics
- Mathematics
- Statistics
- Sampling Design
- Sample Size